Today: 10 June 2026
Strategy stock tumbles after hours as bitcoin slide and $12.4 bln loss jolt MSTR
5 February 2026
1 min read

Strategy stock tumbles after hours as bitcoin slide and $12.4 bln loss jolt MSTR

New York, Feb 5, 2026, 16:38 EST — After-hours

  • Strategy shares fell 17% in late trading, following another decline in bitcoin
  • The company posted a quarterly net loss of $12.4 billion, driven mainly by bitcoin mark-to-market fluctuations
  • Investors are tuning in to a 5 p.m. ET webcast, seeking insights on funding strategies and how quickly future purchases might roll out

Strategy Inc shares dropped 17% to $106.99 in after-hours trading Thursday, dragged down by another steep fall in bitcoin. The cryptocurrency slid about 13%, hovering near $63,460, weighing on crypto-related stocks once more.

This matters because Strategy has emerged as one of the top U.S. stock proxies for bitcoin, with its link growing stronger as the company loaded up on the token. When bitcoin falters, Strategy’s stock tends to swing even more sharply.

Investors are now focused on how long the company can continue raising funds if the crypto downturn persists. The real concern isn’t software revenue, but rather how long the balance sheet can hold up.

Strategy reported a fourth-quarter net loss of $12.4 billion, including an operating loss of $17.4 billion driven entirely by $17.4 billion in unrealized losses on digital assets under fair value accounting. CEO Phong Le highlighted that the company raised $25.3 billion in 2025 and added 41,002 bitcoins in January. Executive Chairman Michael Saylor described their bitcoin holdings as a “digital fortress.” Strategy

The company held 713,502 bitcoins as of Feb. 1, with a cost basis of $54.26 billion, or $76,052 per coin, according to Reuters. Strategy shares dropped roughly 47.5% in 2025, compared to a 6.4% decline in bitcoin, highlighting the stock’s leveraged exposure to the crypto asset.

Fair value accounting requires the company to mark its bitcoin holdings to market every quarter, pushing any paper gains or losses straight through earnings. This can cause reported results to fluctuate wildly, even when no sales occur.

On Thursday, Strategy’s reported $123 million in quarterly revenue barely registered. Instead, attention fixated on bitcoin’s trajectory and how funding was unfolding.

Crypto-linked stocks slipped across the board as Strategy dropped. Coinbase fell roughly 13%, with miners Marathon Digital and Riot Platforms sliding about 18% and 15%, respectively, in late trading.

On the Street, Canaccord Genuity’s Joseph Vafi slashed his price target for Strategy to $185 from $474 but held firm on a buy rating, according to GuruFocus.

The risk scenario remains largely the same: a further drop in bitcoin would worsen mark-to-market losses and might limit Strategy’s chances to secure new funding on favorable terms. Should bitcoin hold steady, the strain on earnings and financing could lighten just as fast.

Strategy’s webcast kicks off around 5 p.m. ET. Investors will be tuned in, watching closely for any changes in reserve strategies, plans for raising capital, and the timing of upcoming bitcoin buys ahead of U.S. trading reopening Friday.

Stock Market Today

  • Palantir Technologies (PLTR) Shares Seen Fairly Valued Amid Recent Decline
    June 10, 2026, 5:48 PM EDT. Palantir Technologies has seen its share price fall 13.2% over the past week and 21.3% year to date, following extraordinary gains in prior years. At $132.07 per share, Palantir trades slightly below its estimated intrinsic value of $145.11 based on a Discounted Cash Flow (DCF) analysis, suggesting a modest 9% discount. The company posted $2.69 billion in free cash flow over the past twelve months, with projections rising to $16.11 billion by 2030. Despite recent volatility tied to sentiment on artificial intelligence and software spending, Palantir remains fairly valued but not a clear bargain. Investors should monitor further market developments and valuation metrics to gauge future opportunities or risks.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
Dow Jones today: Index slides about 1% as Alphabet capex plan stirs fresh AI jitters
Previous Story

Dow Jones today: Index slides about 1% as Alphabet capex plan stirs fresh AI jitters

Robinhood stock tumbles nearly 10% as bitcoin breaks lower with earnings days away
Next Story

Robinhood stock tumbles nearly 10% as bitcoin breaks lower with earnings days away

Go toTop